Spikevax (Moderna COVID-19 Vaccine)

Chemical NameCOVID-19 Vaccine, mRNA
Dosage FormInjection (intramuscular; 0.5mL)
Drug ClassVaccines
SystemRespiratory
CompanyModerna
Approval Year20222

Indication

  • Indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older
Last updated on 4/23/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Spikevax (COVID-19 Vaccine, mRNA) Prescribing Information. 2022Moderna US, Inc., Cambridge, MA
Document TitleYearSource
Assessment report: COVID-19 vaccine Moderna. 2021EMA